These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36768234)

  • 1. Opposite Modulation of the NMDA Receptor by Glycine and S-Ketamine and the Effects on Resting State EEG Gamma Activity: New Insights into the Glutamate Hypothesis of Schizophrenia.
    Haaf M; Curic S; Rauh J; Steinmann S; Mulert C; Leicht G
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycine attenuates impairments of stimulus-evoked gamma oscillations in the ketamine model of schizophrenia.
    Haaf M; Curic S; Steinmann S; Rauh J; Leicht G; Mulert C
    Neuroimage; 2022 May; 251():119004. PubMed ID: 35176492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine Alters Functional Gamma and Theta Resting-State Connectivity in Healthy Humans: Implications for Schizophrenia Treatment Targeting the Glutamate System.
    Curic S; Andreou C; Nolte G; Steinmann S; Thiebes S; Polomac N; Haaf M; Rauh J; Leicht G; Mulert C
    Front Psychiatry; 2021; 12():671007. PubMed ID: 34177660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the mGluR allosteric modulation in the NMDA-hypofunction model of schizophrenia.
    Doreulee N; Alania M; Mitaishvili E; Chikovani M; Chkhartishvili B
    Georgian Med News; 2009 Dec; (177):59-65. PubMed ID: 20090156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcosine (glycine transporter inhibitor) attenuates behavioural and biochemical changes induced by ketamine, in the rat model of schizophrenia.
    Kumar A; Akhtar A; Kuhad A; Sah SP
    Exp Brain Res; 2023 Feb; 241(2):451-467. PubMed ID: 36577922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 40 Hz Auditory Steady-State Response Is a Pharmacodynamic Biomarker for Cortical NMDA Receptors.
    Sivarao DV; Chen P; Senapati A; Yang Y; Fernandes A; Benitex Y; Whiterock V; Li YW; Ahlijanian MK
    Neuropsychopharmacology; 2016 Aug; 41(9):2232-40. PubMed ID: 26837462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ketamine and D-cycloserine on the high frequency resting EEG spectrum in humans.
    Nottage JF; Gabay A; De Meyer K; Herrik KF; Bastlund JF; Christensen SR; Gijsen S; Mehta MA
    Psychopharmacology (Berl); 2023 Jan; 240(1):59-75. PubMed ID: 36401646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced auditory evoked gamma-band response and schizophrenia-like clinical symptoms under subanesthetic ketamine.
    Curic S; Leicht G; Thiebes S; Andreou C; Polomac N; Eichler IC; Eichler L; Zöllner C; Gallinat J; Steinmann S; Mulert C
    Neuropsychopharmacology; 2019 Jun; 44(7):1239-1246. PubMed ID: 30758327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in interhemispheric gamma-band connectivity are related to the emergence of auditory verbal hallucinations in healthy subjects during NMDA-receptor blockade.
    Thiebes S; Steinmann S; Curic S; Polomac N; Andreou C; Eichler IC; Eichler L; Zöllner C; Gallinat J; Leicht G; Mulert C
    Neuropsychopharmacology; 2018 Jun; 43(7):1608-1615. PubMed ID: 29453445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamatergic Deficits in Schizophrenia - Biomarkers and Pharmacological Interventions within the Ketamine Model.
    Haaf M; Leicht G; Curic S; Mulert C
    Curr Pharm Biotechnol; 2018; 19(4):293-307. PubMed ID: 29929462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Network Model of the Modulation of γ Oscillations by NMDA Receptors in Cerebral Cortex.
    Susin E; Destexhe A
    eNeuro; 2023 Nov; 10(11):. PubMed ID: 37940562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamatergic dysfunction in Schizophrenia.
    Kruse AO; Bustillo JR
    Transl Psychiatry; 2022 Dec; 12(1):500. PubMed ID: 36463316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.
    Northoff G; Richter A; Bermpohl F; Grimm S; Martin E; Marcar VL; Wahl C; Hell D; Boeker H
    Schizophr Res; 2005 Jan; 72(2-3):235-48. PubMed ID: 15560968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do NMDA-R antagonists re-create patterns of spontaneous gamma-band activity in schizophrenia? A systematic review and perspective.
    Bianciardi B; Uhlhaas PJ
    Neurosci Biobehav Rev; 2021 May; 124():308-323. PubMed ID: 33581223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute ketamine dysregulates task-related gamma-band oscillations in thalamo-cortical circuits in schizophrenia.
    Grent-'t-Jong T; Rivolta D; Gross J; Gajwani R; Lawrie SM; Schwannauer M; Heidegger T; Wibral M; Singer W; Sauer A; Scheller B; Uhlhaas PJ
    Brain; 2018 Aug; 141(8):2511-2526. PubMed ID: 30020423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine Alters Lateral Prefrontal Oscillations in a Rule-Based Working Memory Task.
    Ma L; Skoblenick K; Johnston K; Everling S
    J Neurosci; 2018 Mar; 38(10):2482-2494. PubMed ID: 29437929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamatergic deficit and schizophrenia-like negative symptoms: new evidence from ketamine-induced mismatch negativity alterations in healthy male humans.
    Thiebes S; Leicht G; Curic S; Steinmann S; Polomac N; Andreou C; Eichler I; Eichler L; Zöllner C; Gallinat J; Hanganu-Opatz I; Mulert C
    J Psychiatry Neurosci; 2017 Jun; 42(4):273-283. PubMed ID: 28556775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics.
    Hollmann MW; Liu HT; Hoenemann CW; Liu WH; Durieux ME
    Anesth Analg; 2001 May; 92(5):1182-91. PubMed ID: 11323344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resting-state functional EEG connectivity in salience and default mode networks and their relationship to dissociative symptoms during NMDA receptor antagonism.
    de la Salle S; Choueiry J; Shah D; Bowers H; McIntosh J; Ilivitsky V; Carroll B; Knott V
    Pharmacol Biochem Behav; 2021 Feb; 201():173092. PubMed ID: 33385439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.